FindTrial
Sign In

A Study on evaluation of efficacy of Ondansetron and Palonosetron for prevention of post operative nausea and vomiting.

Comparative Study of the Efficacy of Intravenous Ondansetron Versus Intravenous Palonosetron in the Prevention of Postoperative Nausea and Vomiting in Elective Laparoscopic Surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074272
Enrollment
60
Registered
2024-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: Ondansetron: to study efficacy of intravenous Ondansetron 4mg in prevention of nausea and vomiting for 0-2hours, 2-6hours, 6-24 hours postoperatively Control Intervention1: Palonosetr

Sponsors

Gulbarga institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American society of Anesthesiologists (ASA) grade I and II Patients giving informed written valid consent. Either sex. Patients scheduled to undergo elective laparoscopic surgeries.

Exclusion criteria

Exclusion criteria: History of allergy to Ondansetron or Palonosetron. Patients posted for emergency surgery. Pregnant History of nausea and vomiting 24hrs prior to surgery. History of motion sickness.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of ondansetron and palonosetron in reducing the incidence of postoperative nausea and vomiting.Timepoint: To compare the efficacy of ondansetron and palonosetron on the incidence of postoperative nausea and vomiting, the postoperative periods of 0-2 hours, 2-6 hours, and 6-24 hours should be considered.—

Secondary

MeasureTime frame
To examine hemodynamic parameters & adverse effects in both groups.Timepoint: 0-2 hours, 2-6hours, 6-24hours postoperative period.—

Countries

India

Contacts

Public ContactDr Anusha Dhage

Gulbarga institute of medical sciences

anudha.dhage@gmail.com9538404005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026